ஸௌட்ஶ்ர் வழிய News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from ஸௌட்ஶ்ர் வழிய. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In ஸௌட்ஶ்ர் வழிய Today - Breaking & Trending Today
Aditya Medisales case: Sebi accepts settlement pleas of Sun Pharma, promoters SECTIONS Last Updated: Feb 11, 2021, 04:13 PM IST Share Synopsis Sebi had initiated a probe against Sun Pharma, its managing director Dilip Shanghvi and its directors on the basis of two whistleblower complaints. ET Online Sebi had initiated a probe against Sun Pharma, its managing director Dilip Shanghvi and its directors on the basis of two whistleblower complaints. INSIGHTS NSE Explore Now MUMBAI: The Securities and Exchange Board of India (Sebi) today disposed of charges against Sun Pharmaceutical Industries, and its promoters and directors for alleged diversion of funds through its subsidiary Aditya Medisales, after all the plaintiffs in the case filed a settlement plea. ....
Sun Pharmaceutical Industries along with seven of its executives including Dilip Shanghvi (managing director) and Sudhir Valia (director) has settled a pending dispute with the Securities and Exchange Board of India (Sebi) by agreeing to pay a cumulative penalty of Rs 2.92 crore. Sun Pharma has agreed to pay Rs 56 lakh, while Shanghvi will pay Rs 62.3 lakh, and Valia Rs 37.4 lakh. Other individuals have agreed to pay between Rs 18.5 lakh and Rs 37.4 lakh. The matter pertains to violation of related party norms and allegations of fund diversion. Two whistle-blowers had alleged that Sun Pharma and its wholly owned subsidiary Sun Pharmaceutical Laboratories had been diverting funds through Aditya Medisales, its sole distributor in India. It was further alleged that the diversion continued for several years but Sun Pharma had declared Aditya Medisales as a related party only in 2017-18. ....
Sun Pharmaceuticals Industries and its founder and MD Dilip Singhvi have settled a case with market regulator SEBI with regard to allegations of funds diversion. Others who have settled the case inclu ....